Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 13, 2003 - Issue 4
Submit an article Journal homepage
31
Views
3
CrossRef citations to date
0
Altmetric
Review

Therapeutic strategies in Huntington’s disease

Jordi Alberch Departament de Biologia Cel-lular i Anatomia Patològica, Facultat de Medicina, Universitat de Barcelona, IDIBAPS, Casanova, 143. 08036 Barcelona, Spain
,
Josep M Canals Departament de Biologia Cel-lular i Anatomia Patològica, Facultat de Medicina, Universitat de Barcelona, IDIBAPS, Casanova, 143. 08036 Barcelona, Spain
&
Esther Pérez-Navarro Departament de Biologia Cel-lular i Anatomia Patològica, Facultat de Medicina, Universitat de Barcelona, IDIBAPS, Casanova, 143. 08036 Barcelona, Spain
Pages 449-465 | Published online: 02 Mar 2005

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

John A McCauley. (2006) Amide-containing NR2B/NMDA receptor antagonists. Expert Opinion on Therapeutic Patents 16:6, pages 863-870.
Read now
John A McCauley. (2005) NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004. Expert Opinion on Therapeutic Patents 15:4, pages 389-407.
Read now

Articles from other publishers (1)

Frederik Börgel, Marina Szermerski, Julian A. Schreiber, Louisa Temme, Nathalie Strutz‐Seebohm, Kirstin Lehmkuhl, Dirk Schepmann, Simon M. Ametamey, Guiscard Seebohm, Thomas J. Schmidt & Bernhard Wünsch. (2018) Synthesis and Pharmacological Evaluation of Enantiomerically Pure GluN2B Selective NMDA Receptor Antagonists. ChemMedChem 13:15, pages 1580-1587.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.